These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4399397)
1. Penicillamine and analogous chelating agents. Aposhian HV Ann N Y Acad Sci; 1971 Jul; 179():481-6. PubMed ID: 4399397 [No Abstract] [Full Text] [Related]
2. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine. Borthwick TR; Benson GD; Schugar HJ J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013 [TBL] [Abstract][Full Text] [Related]
3. A mechanism for the action of penicillamine in the treatment of Wilson's disease. Peisach J; Blumberg WE Mol Pharmacol; 1969 Mar; 5(2):200-9. PubMed ID: 4306792 [No Abstract] [Full Text] [Related]
4. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Walshe JM Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043 [No Abstract] [Full Text] [Related]
6. The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance. Gibbs K; Walshe JM Clin Sci Mol Med; 1977 Oct; 53(4):317-20. PubMed ID: 913055 [TBL] [Abstract][Full Text] [Related]
8. The discovery of the therapeutic use of D-penicillamine. Walshe JM J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875 [TBL] [Abstract][Full Text] [Related]
9. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease]. Atsuba Y; Nakahachi T; Terai T; Kozakai T No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072 [No Abstract] [Full Text] [Related]
11. Non-invasive testing for Wilson disease: revisiting the d-penicillamine challenge test. Schilsky ML J Hepatol; 2007 Aug; 47(2):172-3. PubMed ID: 17570556 [No Abstract] [Full Text] [Related]
12. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease. Walshe JM QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540 [TBL] [Abstract][Full Text] [Related]
13. Wilson's disease: assessment of D-penicillamine treatment. Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361 [TBL] [Abstract][Full Text] [Related]
14. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result]. Hamza B; el-Kamel M Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182 [No Abstract] [Full Text] [Related]
15. [Urine copper determination in Wilson's disease during therapy]. Schnack H Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588 [No Abstract] [Full Text] [Related]
16. [Experiences with penicillamine in Wilson's disease]. Lössner J; Bachmann H; Eichner B Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635 [TBL] [Abstract][Full Text] [Related]
17. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease. Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731 [TBL] [Abstract][Full Text] [Related]